chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2-3 weeks after shot, my father developed shingles; Has not received his second dose since the first one was given in February; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February). At the time of the report, HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Event occurred 2-3 weeks after first dose. His second dose was scheduled 17Mar2021 but he missed this appointment due to his illness.
Pt recvd vax 15JUL92 & fainted immed following vax; pt recovered the same day; No further details were provided;
PT received monovalent moderna covid vaccine instead of bivalent. Her other moderna vaccination  dates are 3/1/21, 3/29/21, 11/4/21, 7/27/22
Headache Narrative: HAD FATIGUE, REDNESS TO LT ARM WITH SORENESS AND HEADACHE
Baseball sized firm spot on arm of injection and half dollar sized red itchy spot at site of injection as reported to us by MD office.
Headache; soreness in her left arm; This is spontaneous report from a contactable consumer (patient) reported for herself. The 75-year-old female patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: unknown, Expiry date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location, on an unspecified date (age at vaccination was 75 years) as UNKNOWN, SINGLE dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The caller stated that she got the vaccine shot yesterday and she felt good all day. She stated that she woke up at 10:30 and had a bad headache and soreness in her arm on an unspecified date. Stated that the soreness was going away. Wanted to know the best pain medication to take for a headache. Clarified that she had the Pfizer Covid 19 vaccine. Clarified that it was the left arm that was sore. The outcome of the events was unknown.  Information on Lot/Batch has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Right lower arm swollen, tender to touch, feverish and reddened the next day, post vax. Client also complained of "feeling dizzy and blacked out". Client to clinic on 11/30/00 with right lower arm area swollen, reddened and less tender to touch and less feverish. Client advised to apply cold compress to area and take Benadryl as needed.
could barely walk home; went to bed and stay at home I could hardly move; dizziness (for three days); nausea (for three days); Chills (for three days); This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could barely walk home), MOBILITY DECREASED (went to bed and stay at home I could hardly move), DIZZINESS (dizziness (for three days)), NAUSEA (nausea (for three days)) and CHILLS (Chills (for three days)) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced GAIT DISTURBANCE (could barely walk home), MOBILITY DECREASED (went to bed and stay at home I could hardly move), DIZZINESS (dizziness (for three days)), NAUSEA (nausea (for three days)) and CHILLS (Chills (for three days)). On 28-Feb-2021, DIZZINESS (dizziness (for three days)), NAUSEA (nausea (for three days)) and CHILLS (Chills (for three days)) had resolved. At the time of the report, GAIT DISTURBANCE (could barely walk home) and MOBILITY DECREASED (went to bed and stay at home I could hardly move) outcome was unknown.            Treatment medication was not reported. Concomitant medication was not reported.  Patient was not immunocompromised. Patient stated that  having a good health, has unregular blood pressure and sometimes need medication and other times not (which was not related to the vaccine).   This case was linked to US-irms-MOD21-147416 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Sep-2021: follow up received on 26-sep-21, date of birth and new events were added.
1st Dose of Moderna Vaccine delivered Left Arm Intramuscular approx 8:30 am 4/8/21. Left arm pain began (normally as expected by described side effects) in afternoon, however this progressed to more severe pain in evening precluding normal arm movement and causing problems with sleeping. 24 hours later on 4/9/21, symptoms still persisted, and increased in intensity throughout the day. By evening of 4/9/21 (approx 36 hours after vaccine dose) arm pain was extreme with inability to lift or hold weight. Fever, lethargy, nausea set in. Sleeping was near impossible overnight due to extreme arm pain, which was sharp and took my breath away upon any movement and was throbbing even when immobile and non weight bearing. Fever seemed to break sometime at dawn and by 48 hours later, the arm severe arm pain symptoms started to subside with more normal arm pain and movement returning by afternoon of 4/10/21. I did not take any NSAID or other drugs before or during course of side effects. As this was my first dose of vaccine and I am not aware of having been Covid positive previously, the vaccine side effects after the first dose were very unexpected. I have never had any issues with other vaccinations in my life, nor do I have any known allergies. I am of good health with no underlying health conditions.
pt recvd vax 17JAN93 started w/fever 103.6 20NOV92 AM fever returning few hrs activity & appetite dec; rt leg 1 cm red swelling mild lt leg 5cm redness, swelling w/warmth; cellulitis secondary to inject;
Rash on face, hands/arms, legs and trunk. Fever noted. Noted that patient was placed on cetirizine HCl 1mg/ml 1/4 tsp po daily. Also suggested AVEENO baths.
This case was reported by a pharmacist and described the occurrence of Guillain [[name]] Syndrome in a 52 year old female pt who received Engerix-B and Havrix. On 3/3/04, the pt received separate injections of Engerix-B and Havrix. Approximately 36 days, post/vax, on 4/8/04, the pt experienced Guillain [[name]] Syndrome and was hospitalized. The outcome of the event is unknown. Comment: "Guillian [[name]] Syndrome" was assessed as medically serious by Mfr.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2010, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2011, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles.  As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
12/28/21 pt to ED with generalized malaise and poor po intake; FTT x 3-4 months; found to be positive for COVID; no respiratory sx; elevated tropins; NSTEMI; no intervention recommended; pt does not want a feeding tube; supplemental shakes; pt had an episode of A Fib; 2 L O2 via NC; small pleural effusion and enlarged heart; pt went into V Fib arrest and passed away in the hospital
My left side of my face became numb 45 minutes after my vaccination and stayed numb for a couple of hours.   7 days after my shot my arm became red and puffy and a little tender on and around the site of the vaccination.  Day 8 still puffy all around the shoulder.
pt recv vax 6JUL98 & 12JUL98 pt was put to bed & was nl prior to bedtime;13JUL98 pt was found dead;the reporting nurse noted that the pt did not have any fever or resp problems noted @ bedtime;no autopsy was ordered per family request;
Menveo was ordered for patient, only the diluent was administered to the patient at the time of service.  the MOA did not mix the vaccine with the diluent therefore this is an invalid dose and patient will need to come back for his recommended vaccine.  Please remove from his system roster
Had Tdap on 3-10-09, right deltoid. Right arm is now sore with limited ROM in right shoulder. Right deltoid swollen and warm to touch; no redness. Also has red, flat rash anterior torso and neck; denies itching; no rash on back or legs. Noticed rash morning of 3-12-09. Has been taking Ibuprofen for the discomfort.
lt arm swollen, sore where inj was given, pt exp fever;no itching; + redness
Patient states he received the Moderna 2 shot vaccine series "sometime in 2021".  Unable to provide place nor exact dates of administration.  Patient presents to ED with cough, fever, weakness, dizziness, headache.  Patient recently left AMA from subacute rehab placed by hospital at last discharge 2/5/22. The entirety of provided information included in this report.
Case number PHHY2016US009796, an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 606336) website on 18 Jan 2016. This report refers to a 63-years-old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 58201) in left arm on 27 Oct 2015. On 29 Oct 2015, she experienced sore throat and running nose. On an unknown date (reported as Friday), she experienced full flu symptoms with sore throat, coughing and sweating. When the events got worse on the same day night she was treated with TYLENOL. On an unknown date (reported as Saturday morning), she experienced body ache, felt hot and cold. The outcome of the events was not reported. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Breakthrough case admission after 3 vaccines Moderna 2/4/21 lot# 038K20A;  Moderna 3/4/21 lot# 030A21A;  Moderna 11/19/21 lot# 065F21A
Wednesday, 9 days after receiving the shot, I started having sensitivity on right hand middle finger, at night small hives on left elbow,  the next day more itchy hives started appearing on hands, fingers, elbows, back bone of foot, knees, top of foot. Went to doctor on Thursday and was just told I was having an allergic reaction to something, was prescribed Allegra. On  Friday more hives appeared and middle finger of right hand was getting very swollen. I went to Urgent Care on Saturday to see if I could get another diagnoses and was told it was a reaction to the vaccine. I was prescribed steroids for 7 days, I?m on day 2 and it seems to be helping, no more hives appeared but the ones I have are still pretty itchy.
Chills; Chills; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of CHILLS (Chills) and the second episode of CHILLS (Chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis.    No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Nov-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced the first episode of CHILLS (Chills). On 05-Nov-2021, the patient experienced the second episode of CHILLS (Chills). On 06-Nov-2021, last episode of CHILLS (Chills) had resolved. Concomitant medication was not reported.  It was unknown if patient was enrolled in a covid-19 vaccine trial.  Treatment drug was not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Most recent FOLLOW-UP information incorporated above includes: On 03-Dec-2021: Suspect booster regimen added. Chill after booster dose added as event.
This case was reported by a healthcare professional and described the occurrence of cellulitis in a subject of unspecified age and gender who was vaccinated with INFANRIX (GlaxoSmithKline). On an unspecified date the subject received 4th dose of INFANRIX (unknown). At an unspecified time after vaccination with INFANRIX, the subject experienced cellulitis and was hospitalized. The reporter believes that there might be a quality assurance problem that caused the adverse event. This was considered to be a product complaint. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were probably related to vaccination with INFANRIX. The representative was not sure if the INFANRIX was in prefilled syringes or vials. Linked cases include A0772419A and A0772420A.
Red spots on back and chest, showed 10 days after vaccination. Patient went to Medical Center on 17 Nov 12 and states was prescribed Benadryl. Patient had follow up visit with Dr on 20 Nov 12 and was exempted from future Smallpox vaccine.
Immediate dry mouth and agitation - drank water to try to combat dry mounth 1 minute marker - tightness in throat, difficulty swallowing and slight confusion begins - drank more water and began to suck on lollipop 5 minute marker - confusion, tightness in throat worsens and lump in throat begins - I alerted medical staff who attended to me and gave me a cold compress.   10 minute marker - Drank water, self administered 2 children's dissolvable Benadryl 20mg  - remained at hospital for one hour under observation.   50 minute marker - throat still tight, lump subsided, difficulty swallowing persists, confusion lessens, extreme dry mouth persists, tingling in extremities comes and goes - self administered 2nd Benadryl 25mg  60 minutes - left clinic 90 minutes - called primary care physician and left a message 3 hours - primary care responded to take prednisone 20 - 40 mg every 6 hours for 2 days. 3 hours 20 minutes -  all symptoms described above subsided.   Prednisone was taken for 36 hours as tightness in throat, issue swallowing and lump came back when I tried to stop the Prednisone at 48 hours.
Myocarditis  Chest pain  Brain fog memory  Veins  High blood pressure
tested positive for Covid virus; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient had the Pfizer Covid vaccine first dose on 14Jan2021. On 21Jan2021 she tested positive for Covid virus and on 22Jan2021 had the antibody infusion. She had completed her quarantine and was back at work and to get the second dose which was scheduled for next Thursday, 04Feb2021. She wanted to know if she should get the second did or not. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Information has been received from a nurse concerning a 13 year old female patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (Lot # and route not reported). It was reported that the patient might also received a dose of influenza virus vaccine (unspecified) (Lot# unknown (manufactured unknown). The nurse reported that the patient experienced a localized reaction after receiving VARIVAX (Merck). The patient went to the emergency room but was not admitted to the hospital. On 19-OCT-2010, the patient had recovered. Follow up information has been received via telephone call from the nurse indicating that the female patient was seen the next day by the physician and had recovered. The health care professional contacted during telephone follow up could not supply the following information: patient name, date of birth, dates of vaccination, lot number. This is one of several reports from the same source. No further information is available.
No additional AEs; administration of expired PROQUAD vaccine to 2 patients; This spontaneous report was received from a registered nurse and refers to a 6-year-old female patient.  The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported.  On 29-SEP-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, at a dose of 0.5ml, lot number: U009260, which was determined to be valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD), with an expiration date reported as: 19-SEP-2022 (route of administration, and anatomical site of injection were not reported) as prophylaxis (expired product administered). No additional adverse event was reported.  This is one of two reports from the same reporter.; Sender's Comments:  US-009507513-2209USA009292:
Headache Body aches Chills Fatigue  Fever Alternated Motrin/Tylenol  Felt somewhat better in the evening on march 6th March 7 - still very fatigued and headache March 8 - better, still a bit weak. Went to work.
Vaccine given 12/1/22 one day after expiration of 11/30/22. Pfizer contacted and verified vaccine still effective, no additional dose needed. Family contacted and made aware of event.
No additional AEs; MMR II was administered via IM route instead of SC; This spontaneous report has been received from a registered nurse concerning a 62-year-old male patient. His concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided.   On 09-FEB-2023, the patient was vaccinated with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II) 0.5 ml once, administered as prophylaxis, lot number U014655 with expiration date 07-MAY-2023. The patient was vaccinated intramuscularly instead of subcutaneous route (Incorrect route of product administration). No additional adverse events were reported (No adverse event).
I had bruises down my left arm to my elbow for 1 week after then I started having pain when I lifted both arms higher then my shoulders causing a burning pain down my spine. Almost like hot barbed wire  wrapped around the spine
This spontaneous report was received from a nurse referring to a 44 year old male patient. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were reported as "none". The patient's concurrent conditions were not provided. On 12-AUG-2017, the patient was vaccinated with a dose PROQUAD, subcutaneous, for "vaccination" (dose, lot # and expiration date were not reported). Other suspect therapies included M-M-R II (dose, route, lot # and expiration date were not reported). Concomitant therapies included sterile diluent (STERILE DILUENT). On 15-AUG-2017 (reported as "3 to 4 days after injection") , the patient experienced influenza like symptoms, was achy and fatigued. No treatment was given for the adverse events. The reporting nurse stated that "the confusion was human error, and that the person administering the dose though they were giving M-M-R II"(product name confusion). At the time of reporting the outcome of the adverse events was reported as recovered. A product quality complaint was not involved. The causality assessment between the adverse events and the suspect therapies was not provided.
Feeling strange; Itching at injection; Swollen at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038k20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included METFORMIN for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site). At the time of the report, FEELING ABNORMAL (Feeling strange), INJECTION SITE PRURITUS (Itching at injection) and VACCINATION SITE SWELLING (Swollen at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications also included unspecified supplements and medicine for blood pressure.  Treatment medications was not provided by the reporter
G45.9 TRANSIENT CEREBRAL ISCHEMIA 6/3/2021 INTRACTABLE NAUSEA AND VOMITING G62.9 PERIPHERAL NEUROPATHY 6/3/2021 INTRACTABLE NAUSEA AND VOMITING I21.4 ACUTE NON ST ELEVATION MI 11/16/2021 INTRACTABLE NAUSEA AND VOMITING G45.9 TRANSIENT CEREBRAL ISCHEMIA 6/3/2021 CHEST PAIN G62.9 PERIPHERAL NEUROPATHY 6/3/2021 CHEST PAIN I21.4 ACUTE NON ST ELEVATION MI 11/16/2021 CHEST PAIN G45.9 TRANSIENT CEREBRAL ISCHEMIA 6/3/2021 ACUTE NON ST ELEVATION MI G62.9 PERIPHERAL NEUROPATHY 6/3/2021 ACUTE NON ST ELEVATION MI I21.4 ACUTE NON ST ELEVATION MI 11/16/2021 ACUTE NON ST ELEVATION MI G45.9 TRANSIENT CEREBRAL ISCHEMIA 6/3/2021 FAILURE TO THRIVE SYNDROME, ADULT G62.9 PERIPHERAL NEUROPATHY 6/3/2021 FAILURE TO THRIVE SYNDROME, ADULT I21.4 ACUTE NON ST ELEVATION MI 11/16/2021 FAILURE TO THRIVE SYNDROME, ADULT G45.9 TRANSIENT CEREBRAL ISCHEMIA 6/3/2021 GASTRIC MASS G62.9 PERIPHERAL NEUROPATHY 6/3/2021 GASTRIC MASS I21.4 ACUTE NON ST ELEVATION MI 11/16/2021 GASTRIC MASS
This spontaneous report as received from a pharmacist refers to an unspecified patients of unknown age and unknown gender. On an unknown date, the unspecified patients were vaccinated with doses of improperly stored GARDASIL. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.